Brief: Immunocore Sees Existing Cash, Equivalents Sufficient End Of 2022

Immunocore Holdings

25/03/2021 11:04

March 25 (Reuters) - Immunocore Holdings PLC  IMCR.O :
    * IMMUNOCORE - SEES EXISTING CASH, EQUIVALENTS IS SUFFICIENT
TO
ENABLE TO FUND PLANNED OPERATING EXPENSES & CAPEX  REQUIREMENTS
THROUGH AT LEAST END OF 2022

Source text for Eikon:  ID:nGNEPl7rW 
Further company coverage:  IMCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))